Cwm LLC Purchases 85 Shares of STERIS plc (NYSE:STE)

Cwm LLC grew its position in shares of STERIS plc (NYSE:STE) by 3.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,291 shares of the medical equipment provider’s stock after purchasing an additional 85 shares during the period. Cwm LLC’s holdings in STERIS were worth $503,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Russell Investments Group Ltd. raised its holdings in shares of STERIS by 8.3% in the 1st quarter. Russell Investments Group Ltd. now owns 58,841 shares of the medical equipment provider’s stock valued at $13,235,000 after acquiring an additional 4,494 shares in the last quarter. State Board of Administration of Florida Retirement System raised its stake in STERIS by 3.2% in the first quarter. State Board of Administration of Florida Retirement System now owns 106,346 shares of the medical equipment provider’s stock valued at $23,909,000 after purchasing an additional 3,342 shares in the last quarter. Caden Capital Partners LP lifted its position in STERIS by 80.0% during the fourth quarter. Caden Capital Partners LP now owns 82,312 shares of the medical equipment provider’s stock valued at $18,096,000 after purchasing an additional 36,576 shares during the last quarter. Cullen Investment Group LTD. bought a new stake in STERIS during the fourth quarter valued at approximately $1,351,000. Finally, Diversify Advisory Services LLC bought a new position in shares of STERIS in the 1st quarter worth $903,000. Institutional investors own 94.69% of the company’s stock.

STERIS Trading Down 0.9 %

Shares of STE stock opened at $233.94 on Tuesday. The business has a 50-day moving average of $225.43 and a 200 day moving average of $223.10. The company has a debt-to-equity ratio of 0.49, a current ratio of 3.08 and a quick ratio of 2.36. STERIS plc has a 1-year low of $195.47 and a 1-year high of $243.37. The stock has a market capitalization of $23.13 billion, a PE ratio of 61.24 and a beta of 0.83.

STERIS (NYSE:STE) last released its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.98 by $0.16. STERIS had a return on equity of 13.89% and a net margin of 7.36%. The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the firm posted $2.00 earnings per share. The business’s quarterly revenue was down .4% compared to the same quarter last year. As a group, sell-side analysts anticipate that STERIS plc will post 9.16 earnings per share for the current year.

STERIS Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 20th. Stockholders of record on Thursday, September 5th will be paid a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 0.97%. This is an increase from STERIS’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Thursday, September 5th. STERIS’s dividend payout ratio is 59.69%.

Analyst Ratings Changes

Several brokerages recently issued reports on STE. JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research report on Wednesday, August 7th. Stephens reiterated an “overweight” rating and issued a $260.00 price objective on shares of STERIS in a report on Wednesday, August 7th. StockNews.com raised STERIS from a “hold” rating to a “buy” rating in a report on Tuesday. Piper Sandler reaffirmed a “neutral” rating and issued a $225.00 target price (up previously from $220.00) on shares of STERIS in a research note on Friday, May 10th. Finally, Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research note on Thursday, August 8th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $243.60.

Insider Transactions at STERIS

In related news, Director Christopher S. Holland sold 473 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $239.68, for a total transaction of $113,368.64. Following the transaction, the director now owns 582 shares in the company, valued at approximately $139,493.76. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, VP Renato Tamaro sold 1,154 shares of the firm’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $231.64, for a total value of $267,312.56. Following the completion of the sale, the vice president now directly owns 6,677 shares of the company’s stock, valued at approximately $1,546,660.28. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Christopher S. Holland sold 473 shares of the business’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $239.68, for a total transaction of $113,368.64. Following the transaction, the director now owns 582 shares in the company, valued at approximately $139,493.76. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.